OVOL3
gene geneOn this page
Also known as HOVO3
Summary
OVOL3 (ovo like zinc finger 3, HGNC:14186) is a protein-coding gene on chromosome 19q13.12, encoding Putative transcription factor ovo-like protein 3 (O00110). May act as a transcription regulator.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in epidermal cell differentiation and regulation of transcription by RNA polymerase II. Predicted to be located in chromatin. Predicted to be active in nucleus.
Source: NCBI Gene 728361 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001302757
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14186 |
| Approved symbol | OVOL3 |
| Name | ovo like zinc finger 3 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HOVO3 |
| Ensembl gene | ENSG00000105261 |
| Ensembl biotype | protein_coding |
| OMIM | 616442 |
| Entrez | 728361 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000585332, ENST00000633214, ENST00000925888
RefSeq mRNA: 1 — MANE Select: NM_001302757
NM_001302757
CCDS: CCDS82333
Canonical transcript exons
ENST00000633214 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000698035 | 36113453 | 36113711 |
| ENSE00003748129 | 36112760 | 36112964 |
| ENSE00003780106 | 36111369 | 36111433 |
| ENSE00003783238 | 36111143 | 36111296 |
Expression profiles
Bgee: expression breadth ubiquitous, 108 present calls, max score 68.97.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 68.97 | gold quality |
| left testis | UBERON:0004533 | 68.01 | gold quality |
| testis | UBERON:0000473 | 66.92 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 62.98 | gold quality |
| vastus lateralis | UBERON:0001379 | 59.82 | gold quality |
| quadriceps femoris | UBERON:0001377 | 59.78 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 58.19 | gold quality |
| cerebellar vermis | UBERON:0004720 | 57.59 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 56.98 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 55.97 | gold quality |
| thymus | UBERON:0002370 | 55.80 | silver quality |
| frontal pole | UBERON:0002795 | 50.41 | gold quality |
| cerebellum | UBERON:0002037 | 50.38 | gold quality |
| sural nerve | UBERON:0015488 | 50.34 | silver quality |
| middle frontal gyrus | UBERON:0002702 | 50.30 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 50.25 | gold quality |
| paraflocculus | UBERON:0005351 | 50.18 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 50.18 | gold quality |
| cerebellar cortex | UBERON:0002129 | 50.08 | gold quality |
| pituitary gland | UBERON:0000007 | 49.24 | gold quality |
| adenohypophysis | UBERON:0002196 | 49.15 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 48.57 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 48.47 | gold quality |
| esophagus mucosa | UBERON:0002469 | 48.31 | gold quality |
| apex of heart | UBERON:0002098 | 47.70 | gold quality |
| primary visual cortex | UBERON:0002436 | 46.87 | gold quality |
| endometrium epithelium | UBERON:0004811 | 46.85 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 45.63 | silver quality |
| skin of abdomen | UBERON:0001416 | 45.58 | gold quality |
| fundus of stomach | UBERON:0001160 | 44.68 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.19 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Molecular phylogeny of OVOL1, OVOL2 and OVOL3 genes illustrates a conserved C2H2 zinc finger domain coupled by hypervariable unstructured regions in humans and other species (PMID:22737237)
Cross-species orthologs
11 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | plagx | ENSDARG00000036855 |
| danio_rerio | ovol1a | ENSDARG00000076472 |
| danio_rerio | plagl2 | ENSDARG00000076657 |
| danio_rerio | ovol1b | ENSDARG00000078256 |
| mus_musculus | Ovol3 | ENSMUSG00000100512 |
| rattus_norvegicus | Ovol3 | ENSRNOG00000062751 |
| drosophila_melanogaster | hb | FBGN0001180 |
| drosophila_melanogaster | CG12391 | FBGN0033581 |
| caenorhabditis_elegans | WBGENE00001824 | |
| caenorhabditis_elegans | WBGENE00003033 | |
| caenorhabditis_elegans | WBGENE00012385 |
Paralogs (29): ZNF446 (ENSG00000083838), REST (ENSG00000084093), ZNF174 (ENSG00000103343), PLAGL1 (ENSG00000118495), ZSCAN18 (ENSG00000121413), ZNF576 (ENSG00000124444), OVOL2 (ENSG00000125850), PLAGL2 (ENSG00000126003), ZSCAN5A (ENSG00000131848), ZSCAN29 (ENSG00000140265), ZSCAN32 (ENSG00000140987), ZSCAN1 (ENSG00000152467), ZNF18 (ENSG00000154957), ZKSCAN2 (ENSG00000155592), ZNF496 (ENSG00000162714), ZNF202 (ENSG00000166261), ZNF641 (ENSG00000167528), ZNF444 (ENSG00000167685), SCAND1 (ENSG00000171222), ZNF274 (ENSG00000171606), ZNF131 (ENSG00000172262), OVOL1 (ENSG00000172818), ZNF518A (ENSG00000177853), ZNF518B (ENSG00000178163), PLAG1 (ENSG00000181690), ZSCAN5B (ENSG00000197213), ZNF770 (ENSG00000198146), PEG3 (ENSG00000198300), ZSCAN5C (ENSG00000204532)
Protein
Protein identifiers
Putative transcription factor ovo-like protein 3 — O00110 (reviewed: O00110)
All UniProt accessions (2): O00110, A0AA75L0V4
UniProt curated annotations — full annotation on UniProt →
Function. May act as a transcription regulator.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_001289686* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR027756 | Ovo-like | Family |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF13465
UniProt features (8 total): zinc finger region 4, region of interest 2, chain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O00110-F1 | 68.96 | 0.10 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 74 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, GOBP_REGULATION_OF_EPIDERMIS_DEVELOPMENT, GOBP_KERATINOCYTE_PROLIFERATION, GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS, GOBP_REGULATION_OF_KERATINOCYTE_PROLIFERATION, GOBP_EPIDERMIS_DEVELOPMENT, SCHLOSSER_SERUM_RESPONSE_DN, GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS, GOBP_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION, GOBP_EPITHELIAL_CELL_PROLIFERATION, GOBP_SKIN_DEVELOPMENT, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS
GO Biological Process (8): regulation of transcription by RNA polymerase II (GO:0006357), epidermal cell differentiation (GO:0009913), negative regulation of signal transduction (GO:0009968), regulation of keratinocyte proliferation (GO:0010837), negative regulation of cell differentiation (GO:0045596), regulation of keratinocyte differentiation (GO:0045616), negative regulation of DNA-templated transcription (GO:0045892), negative regulation of multicellular organismal process (GO:0051241)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| epidermis development | 1 |
| epithelial cell differentiation | 1 |
| signal transduction | 1 |
| regulation of signal transduction | 1 |
| negative regulation of cell communication | 1 |
| negative regulation of signaling | 1 |
| negative regulation of response to stimulus | 1 |
| keratinocyte proliferation | 1 |
| regulation of epithelial cell proliferation | 1 |
| cell differentiation | 1 |
| regulation of cell differentiation | 1 |
| negative regulation of cellular process | 1 |
| negative regulation of developmental process | 1 |
| keratinocyte differentiation | 1 |
| regulation of epidermal cell differentiation | 1 |
| DNA-templated transcription | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| multicellular organismal process | 1 |
| negative regulation of biological process | 1 |
| regulation of multicellular organismal process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
250 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OVOL3 | PRODH2 | Q9UF12 | 531 |
| OVOL3 | TMEM221 | A6NGB7 | 519 |
| OVOL3 | SNX32 | Q86XE0 | 494 |
| OVOL3 | LHFPL7 | Q6ICI0 | 478 |
| OVOL3 | GPR137C | Q8N3F9 | 477 |
| OVOL3 | SDHAF1 | A6NFY7 | 475 |
| OVOL3 | BANF2 | Q9H503 | 458 |
| OVOL3 | TMEM132E | Q6IEE7 | 441 |
| OVOL3 | KAT14 | Q9H8E8 | 409 |
| OVOL3 | RBBP9 | O75884 | 407 |
| OVOL3 | EXOC6B | Q9Y2D4 | 406 |
| OVOL3 | GPR162 | Q16538 | 403 |
| OVOL3 | TMEM171 | Q8WVE6 | 396 |
| OVOL3 | TMEM150C | B9EJG8 | 390 |
| OVOL3 | HLCS | P50747 | 387 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0JNJ4, A2APT9, A2VDT4, A4IHR5, A7UKY7, D3YYM0, F6WEQ6, G5E869, O00110, O00221, O14753, O15015, O70142, O88282, P52746, P98077, Q15654, Q2I689, Q32KV8, Q3U381, Q4R8S8, Q504L7, Q5R4P8, Q6ZN55, Q7TSX9, Q8BI73, Q8BY46, Q8CDC7, Q8CE64, Q8CIV7, Q8IX07, Q8N143, Q96BV0, Q96C00, Q96H86, Q96JB3, Q96T92, Q9BRP0, Q9BU19, Q9DB38
Diamond homologs: A2VDT4, D3YYM0, G5EDU6, O00110, O14753, P51521, Q8CIV7, Q9BRP0, Q9WTJ2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
576 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:36111431:GCG:G | donor_gain | 0.9900 |
| 19:36112757:CAGCA:C | acceptor_gain | 0.9900 |
| 19:36112758:AGCAG:A | acceptor_gain | 0.9900 |
| 19:36112846:GC:G | acceptor_gain | 0.9900 |
| 19:36112965:GTGA:G | donor_loss | 0.9900 |
| 19:36112966:T:A | donor_loss | 0.9900 |
| 19:36111432:CGGT:C | donor_loss | 0.9800 |
| 19:36111434:G:GG | donor_gain | 0.9800 |
| 19:36111434:G:GT | donor_loss | 0.9800 |
| 19:36111435:T:TT | donor_loss | 0.9800 |
| 19:36111436:GAGT:G | donor_loss | 0.9800 |
| 19:36111437:A:AC | donor_loss | 0.9800 |
| 19:36112965:G:GG | donor_gain | 0.9800 |
| 19:36112967:GA:G | donor_loss | 0.9800 |
| 19:36112759:GCAGC:G | acceptor_gain | 0.9700 |
| 19:36112845:A:AG | acceptor_gain | 0.9700 |
| 19:36112846:G:GG | acceptor_gain | 0.9700 |
| 19:36113451:AGG:A | acceptor_gain | 0.9700 |
| 19:36113452:GGG:G | acceptor_gain | 0.9700 |
| 19:36111438:G:C | donor_loss | 0.9600 |
| 19:36112759:GCA:G | acceptor_gain | 0.9600 |
| 19:36112846:GCGC:G | acceptor_gain | 0.9600 |
| 19:36112954:G:GT | donor_gain | 0.9600 |
| 19:36112962:CTG:C | donor_gain | 0.9600 |
| 19:36113447:GTGCA:G | acceptor_loss | 0.9600 |
| 19:36113448:TGCAG:T | acceptor_loss | 0.9600 |
| 19:36113449:GCA:G | acceptor_loss | 0.9600 |
| 19:36113451:A:C | acceptor_loss | 0.9600 |
| 19:36113451:AG:A | acceptor_gain | 0.9600 |
| 19:36113452:GG:G | acceptor_gain | 0.9600 |
AlphaMissense
1238 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:36112919:T:C | F131L | 1.000 |
| 19:36112921:T:A | F131L | 1.000 |
| 19:36112921:T:G | F131L | 1.000 |
| 19:36113491:T:C | F159L | 1.000 |
| 19:36113493:T:A | F159L | 1.000 |
| 19:36113493:T:G | F159L | 1.000 |
| 19:36112835:T:C | F103L | 0.999 |
| 19:36112837:C:A | F103L | 0.999 |
| 19:36112837:C:G | F103L | 0.999 |
| 19:36112862:C:A | H112N | 0.999 |
| 19:36112864:C:A | H112Q | 0.999 |
| 19:36112864:C:G | H112Q | 0.999 |
| 19:36112920:T:C | F131S | 0.999 |
| 19:36112938:T:C | L137P | 0.999 |
| 19:36112946:C:A | H140N | 0.999 |
| 19:36112948:C:A | H140Q | 0.999 |
| 19:36112948:C:G | H140Q | 0.999 |
| 19:36112960:C:A | H144Q | 0.999 |
| 19:36112960:C:G | H144Q | 0.999 |
| 19:36113464:T:C | F150L | 0.999 |
| 19:36113466:C:A | F150L | 0.999 |
| 19:36113466:C:G | F150L | 0.999 |
| 19:36113470:T:C | C152R | 0.999 |
| 19:36113491:T:A | F159I | 0.999 |
| 19:36113492:T:C | F159S | 0.999 |
| 19:36112854:T:C | L109P | 0.998 |
| 19:36112862:C:G | H112D | 0.998 |
| 19:36112876:C:A | H116Q | 0.998 |
| 19:36112876:C:G | H116Q | 0.998 |
| 19:36112915:G:C | K129N | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1001002920 (19:36110273 C>T), RS1001321717 (19:36110557 G>A,C), RS1001398030 (19:36110183 C>G,T), RS1003249044 (19:36112913 A>G), RS1003470 (19:36111827 G>A,C), RS1003537878 (19:36112897 G>A), RS1004023331 (19:36109551 T>C), RS1004520639 (19:36109357 C>G), RS1004742307 (19:36109543 G>A), RS1004858966 (19:36113187 A>G), RS1005662525 (19:36113827 A>C), RS1005859356 (19:36112020 T>C,G), RS1006474528 (19:36113972 C>A,T), RS1007269801 (19:36111233 C>T), RS1008374749 (19:36109666 G>A)
Disease associations
OMIM: gene MIM:616442 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| abrine | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HC87 | HEK293 eGFP-OVOL3 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.